Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Torsten, Böhler"'
Autor:
Qi Wang, Heba Alshaker, Torsten Böhler, Shyam Srivats, Yimin Chao, Colin Cooper, Dmitri Pchejetski
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Many prostate cancers relapse after initial chemotherapy treatment. Combining molecular and chemotherapy together with encapsulation of drugs in nanocarriers provides effective drug delivery and toxicity reduction. We developed core shell li
Externí odkaz:
https://doaj.org/article/beda79c1f26c4da98ebe53b6842a492f
Autor:
Heba Alshaker, Qi Wang, Torsten Böhler, Robert Mills, Mathias Winkler, Tawfiq Arafat, Yoshiaki Kawano, Dmitri Pchejetski
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Resistance to docetaxel is a key problem in current prostate and breast cancer management. We have recently discovered a new molecular mechanism of prostate cancer docetaxel chemoresistance mediated by the mammalian target of rapamycin (mTOR
Externí odkaz:
https://doaj.org/article/20c5fd2861e8459bb0528de169db4eaa
Autor:
Yimin Chao, Torsten Böhler, Colin Cooper, Heba Alshaker, Dmitri Pchejetski, Qi Wang, Shyam Srivats
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Many prostate cancers relapse after initial chemotherapy treatment. Combining molecular and chemotherapy together with encapsulation of drugs in nanocarriers provides effective drug delivery and toxicity reduction. We developed core shell lipid-polym
Autor:
Markus Neubauer, Adriana Boschetti-de-Fierro, Markus Storr, Carina Zweigart, Torsten Böhler, Bernd Krause
Today, most patients who require renal replacement therapy are conventionally treated using dialysis membranes. New developments have been made in the last decade to improve the outcomes for chronic dialysis patients. Cellulose membranes have been re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e625fd651cbfcb263d92cbb643906051
https://doi.org/10.1016/b978-0-12-409547-2.12265-6
https://doi.org/10.1016/b978-0-12-409547-2.12265-6
Autor:
Torsten Böhler, Heba Alshaker, Tawfiq Arafat, Colin Cooper, Dmitri Pchejetski, Qi Wang, Mathias Winkler, Yoshiaki Kawano
Publikováno v:
Oncotarget
Resistance to docetaxel is a key problem in current prostate cancer management. Sphingosine kinase 1 (SK1) and phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathways have been implicated in prostate cancer chemoresistance.
Publikováno v:
Nature Reviews Urology. 8:569-578
Sphingosine kinase 1 (SK1) is a lipid enzyme with oncogenic properties that converts the proapoptotic lipid sphingosine into the antiapoptotic lipid sphingosine-1-phosphate, which activates the signal transduction pathways that lead to cell prolifera
Autor:
Eberhard Wieland, Purevtseren Gurragchaa, Michael Oellerich, Claudia Sommerer, Maria Shipkova, Bertram Hartmann, Klemens Budde, Christoph J Olbricht, Torsten Böhler, Caner Süsal, Moshe Israeli
Publikováno v:
Therapeutic Drug Monitoring. 32:560-572
Therapeutic drug monitoring is a well-established approach in transplantation medicine to guide immunosuppressive therapy. However, it cannot always predict the effects of immunosuppressive drugs on immune cells, because it does not reflect any aspec
Autor:
Nassim Kamar, Lionel Rostaing, Sylvain Galvani, Mogens Thomsen, Jean-Claude Thiers, Y. Zou, Torsten Böhler, Michel Abbal, P. Stastny, Anne Nègre-Salvayre, Nathalie Augé, Cindy Canivet, Robert Salvayre, Federico Sallusto, Denis Calise
Publikováno v:
American Journal of Transplantation
American Journal of Transplantation, 2009, 9 (11), pp.2607-14. ⟨10.1111/j.1600-6143.2009.02804.x⟩
American Journal of Transplantation, Wiley, 2009, 9 (11), pp.2607-2614. ⟨10.1111/j.1600-6143.2009.02804.x⟩
American Journal of Transplantation, Wiley, 2009, 9 (11), pp.2607-14. ⟨10.1111/j.1600-6143.2009.02804.x⟩
American Journal of Transplantation, 2009, 9 (11), pp.2607-14. ⟨10.1111/j.1600-6143.2009.02804.x⟩
American Journal of Transplantation, Wiley, 2009, 9 (11), pp.2607-2614. ⟨10.1111/j.1600-6143.2009.02804.x⟩
American Journal of Transplantation, Wiley, 2009, 9 (11), pp.2607-14. ⟨10.1111/j.1600-6143.2009.02804.x⟩
International audience; Antibodies toward HLA class I and/or MICA are commonly observed in transplanted patients suffering from allograft arteriosclerosis, also called chronic vascular rejection (CVR). The relative importance of cellular versus humor
Autor:
Lionel Rostaing, Petra Glander, Torsten Böhler, Klemens Budde, Lutz Liefeldt, Hans-Hellmut Neumayer, P. Hambach, Jochen Nolting, Nassim Kamar
Publikováno v:
Clinical Journal of the American Society of Nephrology. 4:936-942
Background and objectives: The effect of mycophenolate mofetil (MMF) on T cell function has not been evaluated in patients undergoing kidney transplantation. The aim of this study was to assess the effect of 1g of MMF on T cell function, that is, int
Autor:
Torsten Böhler, Robert Salvayre, Jacques Izopet, Lionel Rostaing, Karl Barange, Laurent Alric, Mogens Thomsen, Fabrice Muscari, Jean-Marie Péron, Bertrand Suc, Dominique Durand, Nassim Kamar, Anne Nègre-Salvayre, Cindy Canivet, Sylvain Galvani
Publikováno v:
Transplant Immunology. 19:112-119
The incidence of acute rejection is significantly higher in hepatitis C virus (HCV) liver-transplant patients than in patients who have received a graft for other liver diseases, i.e., mainly alcoholic cirrhosis. The aim of this study was to assess T